GlassScriptPhysician profile
Sukanya Roy
NPI 1720658222
$1,482.61
in general payments reported to CMS, 2019-2025
11 companies · $533 in 2025
The $533 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.03 · 2022: $263 · 2023: $244 · 2024: $427 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $391.95 | 2022-2024 | Senza |
| Lilly USA, LLC | $203.15 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Inspire Medical Systems, INC. | $201.61 | 2023-2025 | Inspire |
| Shockwave Medical, INC | $133.72 | 2025 | |
| Glaxosmithkline, LLC. | $123.37 | 2023 | Bexsero |
| Novo Nordisk INC | $121.86 | 2025 | Wegovy |
| Teva Pharmaceuticals USA, INC. | $111.97 | 2024 | Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $81.35 | 2025 | Saphnelo |
| Pfizer INC. | $51.32 | 2023 | |
| Exact Sciences Corporation | $46.28 | 2023-2025 | Cologuard Collection Kit |
| Organon LLC | $16.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sukanya Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.